MaxCyte, Inc. (MXCT) Free Cash Flow
MaxCyte, Inc. (MXCT) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2021-12-31 | -$14.51M |
| 2022-12-31 | -$33.26M |
| 2023-12-31 | -$25.39M |
| 2024-12-31 | -$29.26M |
| 2025-12-31 | -$36.18M |
How MXCT compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| ENTA | Enanta Pharmaceuticals Inc. | -$32.17M |
| CRVS | Corvus Pharmaceuticals Inc. | -$32.97M |
| ALDX | Aldeyra Therapeutics Inc. | -$33.35M |
| TENX | — | -$35.80M |
| AVXL | Anavex Life Sciences Corp. | -$39.04M |
These are five companies in the same sector as MXCT with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get MaxCyte, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("MXCT", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | MXCT | $1.39 | +0.72% | 0.62M |
| 3 | ||||
| 4 | ||||
| 5 |